Relay Therapeutics is a clinical-stage precision medicines company focused on transforming the drug discovery process to deliver life-changing therapies to patients. Leveraging unique insights into protein motion and its relationship to protein function, the company aims to effectively target previously intractable protein targets, particularly in the field of targeted oncology. Utilizing their innovative Dynamo platform, Relay Therapeutics integrates advanced experimental and computational methods to enhance small molecule therapeutic discovery. The company prides itself on its world-class team of experts who collaborate closely throughout the drug discovery process, driven by a shared passion for making a significant impact on patient lives.